Table 3

Cost-effectiveness results in three patient subgroups

Clinically guidedBNP-guided
SubgroupCost*QALYs*Cost*QALYs*iNMB† (95% CI)ICER*
HFrEF patients <75 years£58 1395.02£63 5275.57£5424 (£987 to £9469)£9840
HFpEF patients <75 years£67 6945.86£71 0976.23£3155 (−£10 307 to £11 613)£9066
HFrEF patients ≥75 years£26 0932.20£27 6762.39£2267 (−£1524 to £6074)£8123
  • *Deterministic analysis.

  • †Probabilistic sensitivity analysis.

  • ICER, incremental cost-effectiveness ratio; iNMB, incremental net monetary benefit.